Physiologically based pharmacokinetic model for digoxin disposition in dogs and its preliminary application to humans.
暂无分享,去创建一个
[1] M. O'Rourke,et al. Digoxin concentrations in the serum and myocardium of digitalised patients. , 1973, Australian and New Zealand journal of medicine.
[2] C. Klaassen,et al. Biliary excretion of cardiac glycosides. , 1973, The Journal of pharmacology and experimental therapeutics.
[3] B. Johnson,et al. Maximal intestinal absorption of digoxin, and its relation to steady state plasma concentration. , 1975, British heart journal.
[4] D. Greenblatt,et al. Intravenous digoxin as a bioavailability standard: Slow infusion and rapid injection , 1974, Clinical pharmacology and therapeutics.
[5] D. Harrison,et al. Correlation of Serum Concentrations with Heart Concentrations of Digoxin in Human Subjects , 1974, Circulation.
[6] J. Doherty,et al. Tissue concentration and turnover of tritiated digoxin in dogs. , 1966, The American journal of cardiology.
[7] W. Jusko,et al. Digoxin pharmacokinetics: Role of renal failure in dosage regimen design , 1975, Clinical pharmacology and therapeutics.
[8] P. Ongley,et al. The distribution and excretion of tritiated substances in experimental animals following the administration of digoxin-3H. , 1966, The Journal of laboratory and clinical medicine.
[9] E. Adolph,et al. Quantitative Relations in the Physiological Constitutions of Mammals. , 1949, Science.
[10] J. Cannon,et al. Pharmacokinetics of 1-beta-D-arabinofuranosylcytosine (ARA-C) deamination in several species. , 1973, Biochemical pharmacology.
[11] J. Doherty,et al. Tritiated Digoxin: XIV. Enterohepatic Circulation, Absorption, and Excretion Studies in Human Volunteers , 1970, Circulation.
[12] N. Benowitz,et al. Lidocaine disposition kinetics in monkey and man; I. Prediction by a perfusion model , 1974, Clinical pharmacology and therapeutics.
[13] K. Bischoff,et al. Methotrexate pharmacokinetics. , 1971, Journal of pharmaceutical sciences.
[14] H. Halkin,et al. Determinants of the renal clearance of digoxin , 1975, Clinical pharmacology and therapeutics.
[15] Å. Bertler,et al. POST‐MORTEM DISTRIBUTION AND TISSUE CONCENTRATIONS OF DIGOXIN IN INFANTS AND ADULTS , 1975, Acta paediatrica Scandinavica.
[16] J. Doherty,et al. Studies with tritiated digoxin in human subjects after intravenous administration. , 1962, American heart journal.
[17] D. Azarnoff,et al. Absorption of orally given digoxin preparations. , 1972, JAMA.
[18] A. Russell,et al. Digoxin pharmacokinetics: multicompartmental analysis and its clinical implications. , 1976, British journal of clinical pharmacology.
[19] W W MAPLESON,et al. An electric analogue for uptake and exchange of inert gases and other agents. , 1963, Journal of applied physiology.
[20] W. Nelp,et al. RELATIONSHIP OF THE EXCRETION OF TRITIATED DIGOXIN TO RENAL FUNCTION , 1966, The American journal of the medical sciences.
[21] R. Rutherford,et al. Distribution of cardiac output in experimental hemorrhagic shock in dogs. , 1969, Journal of applied physiology.
[22] G. Bounous,et al. REGIONAL BLOOD FLOW AND OXYGEN CONSUMPTION IN EXPERIMENTAL HEMORRHAGIC SHOCK. , 1963, Archives of surgery.
[23] E. Layne,et al. Studies on tritum-labeled digoxin: tissue, blood and urine determinations. , 1960, The Journal of clinical investigation.
[24] V. Manninen,et al. Human serum and myocardium digoxin , 1976, Clinical pharmacology and therapeutics.
[25] Eve Is,et al. A review of the physiology of the gastrointestinal tract in relation to radiation doses from radioactive materials. , 1966 .
[26] M. Gibaldi,et al. Physiologically based pharmacokinetic model for digoxin distribution and elimination in the rat. , 1977, Journal of pharmaceutical sciences.
[27] W. J. Westlake,et al. Problems associated with analysis of pharmacokinetic models. , 1971, Journal of pharmaceutical sciences.
[28] F. Marcus,et al. THE METABOLISM OF DIGOXIN IN NORMAL SUBJECTS. , 1964, The Journal of pharmacology and experimental therapeutics.
[29] R P Forsyth,et al. Lidocaine disposition kinetics in monkey and man; II. Effects of hemorrhage and sympathomimetic drug administration , 1974, Clinical pharmacology and therapeutics.
[30] F. Marcus,et al. The effect of reserpine on the metabolism of tritiated digoxin in the dog and in man. , 1968, The Journal of pharmacology and experimental therapeutics.
[31] F. Marcus,et al. The effect of acute hypokalemia on the myocardial concentration and body distribution of tritiated digoxin in the dog. , 1971, The Journal of pharmacology and experimental therapeutics.
[32] W. Jusko,et al. Myocardial distribution of digoxin and renal function , 1974, Clinical pharmacology and therapeutics.
[33] K. Wakim,et al. Inhibition of Binding of Tritiated Digoxin to Myocardium by Sodium Depletion in Dogs , 1969, Circulation research.
[34] D. Chamberlain,et al. Myocardial and Skeletal Muscle Concentrations of Digoxin in Patients on Long-term Therapy , 1972, British medical journal.